Literature DB >> 33487400

Is It Time to Call Idiopathic Pulmonary Hemosiderosis by the Correct Name: Immune-Mediated Pulmonary Hemosiderosis?

Biplab K Saha1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33487400     DOI： 10.1016/j.amjms.2021.01.006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   3.462


× No keyword cloud information.
  5 in total

Review 1.  Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.

Authors:  Biplab K Saha; Woon H Chong; Nils T Milman
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 3.650

Review 2.  Adult patients with idiopathic pulmonary hemosiderosis: a comprehensive review of the literature.

Authors:  Biplab K Saha; Alyssa Bonnier; Santu Saha; Baidya Nath Saha; Boris Shkolnik
Journal:  Clin Rheumatol       Date:  2022-02-18       Impact factor: 3.650

Review 3.  The Spectrum of Autoantibodies in Adult Patients With Idiopathic Pulmonary Hemosiderosis: A Brief Review of the Literature.

Authors:  Biplab K Saha; Alyssa Bonnier; Santu Saha; Baidya N Saha; Nils T Milman
Journal:  Cureus       Date:  2022-04-15

Review 4.  Comparative Analysis of Adult Patients With Idiopathic Pulmonary Hemosiderosis and Lane-Hamilton Syndrome: A Systematic Review of the Literature in the Period 1971-2022.

Authors:  Biplab K Saha; Praveen Datar; Alexis Aiman; Alyssa Bonnier; Santu Saha; Nils T Milman
Journal:  Cureus       Date:  2022-03-25

Review 5.  Prevalence of autoantibodies in pediatric patients with idiopathic pulmonary hemosiderosis: a scoping review of the literature in the period 1980-2021.

Authors:  Biplab K Saha; Alyssa Bonnier; Praveen Chenna; Nils T Milman
Journal:  Clin Rheumatol       Date:  2022-01-24       Impact factor: 3.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.